Caprelsa 100 mg – DIN 02378582
Caprelsa is Vandetanib 100 mg (tablet), sold in Canada. It is used for thyroid neoplasms. It is supplied by Sanofi-Aventis Canada Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Vandetanib 100 mg
- Brand
- Caprelsa
- Strength
- 100 mg
- Used for
- Thyroid neoplasms
- Form
- Tablet
- Manufacturer
- Sanofi-Aventis Canada Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02378582
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Vandetanib used for?
Vandetanib is used for thyroid neoplasms.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
CAPRELSA is indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.
Use CAPRELSA in patients with indolent, asymptomatic or slowly progressing disease only after careful consideration of the treatment related risks of CAPRELSA.
From the FDA-approved label on DailyMed (published Apr 27, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02378582.
- It names Caprelsa, Vandetanib 100 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Caprelsa by Sanofi-Aventis Canada Inc.
In Canada: prescription only.
Ingredients
Active: Vandetanib